Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve
Giuseppe Tarantini, Marco Mojoli, Paola Purita, Massimo Napodano, Augusto D'Onofrio, Annachiara Frigo, Elisa Covolo, Michela Facchin, Giambattista Isabella, Gino Gerosa, Sabino Iliceto, Giuseppe Tarantini, Marco Mojoli, Paola Purita, Massimo Napodano, Augusto D'Onofrio, Annachiara Frigo, Elisa Covolo, Michela Facchin, Giambattista Isabella, Gino Gerosa, Sabino Iliceto
Abstract
Aims: Early data on the Edwards SAPIEN 3 valve (S3-THV) have shown low rates of paravalvular leaks and vascular complications but relatively high 30-day permanent pacemaker implantation (PPMI) rates. No direct comparisons on clinical outcomes including PPMI rates are available for the S3-THV and the Edwards SAPIEN XT (XT-THV). We aimed to compare the 30-day PPMI rates in patients treated with the two prostheses and to assess the interplay among valve type, depth of implantation and PPMI rate.
Methods and results: Two hundred and nine patients treated by TAVI were considered. The S3-THV was associated with higher PPMI rates compared to the XT-THV, both overall and in subgroups matched for several predictors of PPMI. However, in the S3-THV group, 30-day PPMI was strictly associated with deep valve implantation, and PPMI risk of high-implanted S3-THVs was similar to that of the overall XT-THV matched group. No cases of significant paravalvular leak were observed in the S3-THV group.
Conclusions: The S3-THV was associated with a higher incidence of PPMI compared to the XT-THV. In the S3-THV group, pacemaker implantation was strictly associated with deep valve implantation. An implantation technique involving higher initial placement of the central marker (from 0 to 3 mm above the base of the aortic cusps) and, as a consequence, higher final valve depth might help in preventing post-TAVI PPMI with the S3-THV, without affecting the risk of paravalvular leak.
Source: PubMed